Plab1 - Genetic and Chromosomal Disorders (Al-Hanif Foundation)
•
0 likes•23 views
This document categorizes and describes several genetic disorders by their inheritance patterns. Autosomal recessive disorders like cystic fibrosis and sickle cell anemia have a 25% chance of being passed down from each parent and only affect those who inherit the defective gene from both parents. Autosomal dominant disorders such as Huntington's disease and Marfan syndrome have a 50% chance of being passed down from an affected parent and affect those inheriting one copy of the defective gene. X-linked recessive disorders including hemophilia and Duchene muscular dystrophy have a 50% chance of affecting males who inherit the defective gene from their mother. Trisomies such as Down syndrome occur when individuals are born with an extra copy of chromosome 13
Report
Share
Report
Share
Download to read offline
Recommended
Mds 1
Myelodysplastic syndrome is a clonal hematopoietic stem cell disorder characterized by cytopenias, dysplasia of blood cells, and risk of progression to acute leukemia. It occurs most commonly in elderly patients and is caused by ineffective hematopoiesis where blood cells produced in the bone marrow are abnormal and destroyed early. The disease involves dysplasia of the myeloid, erythroid, and megakaryocytic cell lines and is classified based on the percentage of blasts and cytopenias seen in the bone marrow and peripheral blood.
Myelodysplastic syndrome
Myelodysplastic syndrome (MDS) is a group of hematologic disorders characterized by ineffective hematopoiesis and maturation defects leading to pancytopenia. MDS can be classified according to percentage of blasts and ringed sideroblasts. Common features include peripheral cytopenias, dysplastic changes in the bone marrow, and risk of progression to acute leukemia. Treatment involves supportive care such as blood transfusions, and allogeneic bone marrow transplant may provide long-term remission for some patients.
Myelodysplastic Syndrome
Dr. Kaushalya M K discusses myelodysplastic syndromes (MDS) in the document. Some key points:
1. MDS is a group of clonal hematopoietic stem cell diseases characterized by cytopenia, dysplasia, ineffective hematopoiesis, and increased risk of acute myeloid leukemia.
2. Risk factors for MDS include aging, environmental exposures like smoking and radiation, genetic disorders, and prior chemotherapy or radiation therapy.
3. Symptoms are related to cytopenias and include fatigue, infections, bleeding, and shortness of breath. Diagnosis involves blood tests, bone marrow biopsy, and cytogenetic analysis.
4. Treatment
Myelodysplastic syndrome
The document discusses myelodysplastic syndromes (MDS), a group of stem cell malignancies characterized by ineffective hematopoiesis, cytopenias, and a risk of progression to acute myeloid leukemia. MDS arises from clonal mutations in hematopoietic stem cells and most commonly affects older adults. Diagnosis involves blood tests, bone marrow biopsy and aspiration showing dysplastic changes, and cytogenetic analysis to identify chromosomal abnormalities associated with prognosis. MDS ranges from indolent to aggressive disease depending on factors like karyotype and bone marrow blast percentage.
Aquired aplastic anemia
This document discusses aplastic anemia (AA), a bone marrow failure syndrome characterized by pancytopenia and a hypocellular bone marrow. AA can be idiopathic, secondary to infections, chemicals, drugs, radiation or other causes. Clinical features include easy bruising, fatigue and recurrent infections. Diagnosis involves blood tests and bone marrow biopsy. Treatment options include supportive care with transfusions, immunosuppressive therapy with antithymocyte globulin and cyclosporine, hematopoietic stem cell transplantation, and growth factors. Prognosis depends on treatment, with 5-year survival rates of 68% with immunosuppression and 73% with stem cell transplantation.
Myelodysplastic syndrome (MDS)
This document describes myelodysplastic syndromes (MDS), a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis leading to peripheral blood cytopenias. It discusses the history of MDS classification including the French-American-British (FAB) and World Health Organization (WHO) systems. Key features of the different MDS subtypes are outlined along with associated cytogenetic abnormalities, predisposing factors, theories of pathophysiology, clinical manifestations, and diagnostic evaluation.
Aplastic anemia
This document summarizes the management of aplastic anemia. It discusses the classification, pathogenesis, clinical evaluation, investigations and definitive management including immunosuppressive therapy with antithymocyte globulin and cyclosporine. It also covers supportive management with transfusions, antibiotics and growth factors. Treatment failure options and hematopoietic stem cell transplantation are described. Inherited causes like Fanconi anemia are also summarized.
Refreactory anemia
Refractory anemia is a subtype of myelodysplastic syndrome characterized by non-responsiveness to conventional anemia treatment. It is defined by less than 5% blasts in the bone marrow and less than 1% in the peripheral blood. Refractory anemia involves dysplasia primarily affecting the erythroid lineage. Evaluation includes blood counts, peripheral smear, bone marrow biopsy and cytogenetic testing to confirm the diagnosis and guide prognosis. Management focuses on treating the anemia and related symptoms.
Recommended
Mds 1
Myelodysplastic syndrome is a clonal hematopoietic stem cell disorder characterized by cytopenias, dysplasia of blood cells, and risk of progression to acute leukemia. It occurs most commonly in elderly patients and is caused by ineffective hematopoiesis where blood cells produced in the bone marrow are abnormal and destroyed early. The disease involves dysplasia of the myeloid, erythroid, and megakaryocytic cell lines and is classified based on the percentage of blasts and cytopenias seen in the bone marrow and peripheral blood.
Myelodysplastic syndrome
Myelodysplastic syndrome (MDS) is a group of hematologic disorders characterized by ineffective hematopoiesis and maturation defects leading to pancytopenia. MDS can be classified according to percentage of blasts and ringed sideroblasts. Common features include peripheral cytopenias, dysplastic changes in the bone marrow, and risk of progression to acute leukemia. Treatment involves supportive care such as blood transfusions, and allogeneic bone marrow transplant may provide long-term remission for some patients.
Myelodysplastic Syndrome
Dr. Kaushalya M K discusses myelodysplastic syndromes (MDS) in the document. Some key points:
1. MDS is a group of clonal hematopoietic stem cell diseases characterized by cytopenia, dysplasia, ineffective hematopoiesis, and increased risk of acute myeloid leukemia.
2. Risk factors for MDS include aging, environmental exposures like smoking and radiation, genetic disorders, and prior chemotherapy or radiation therapy.
3. Symptoms are related to cytopenias and include fatigue, infections, bleeding, and shortness of breath. Diagnosis involves blood tests, bone marrow biopsy, and cytogenetic analysis.
4. Treatment
Myelodysplastic syndrome
The document discusses myelodysplastic syndromes (MDS), a group of stem cell malignancies characterized by ineffective hematopoiesis, cytopenias, and a risk of progression to acute myeloid leukemia. MDS arises from clonal mutations in hematopoietic stem cells and most commonly affects older adults. Diagnosis involves blood tests, bone marrow biopsy and aspiration showing dysplastic changes, and cytogenetic analysis to identify chromosomal abnormalities associated with prognosis. MDS ranges from indolent to aggressive disease depending on factors like karyotype and bone marrow blast percentage.
Aquired aplastic anemia
This document discusses aplastic anemia (AA), a bone marrow failure syndrome characterized by pancytopenia and a hypocellular bone marrow. AA can be idiopathic, secondary to infections, chemicals, drugs, radiation or other causes. Clinical features include easy bruising, fatigue and recurrent infections. Diagnosis involves blood tests and bone marrow biopsy. Treatment options include supportive care with transfusions, immunosuppressive therapy with antithymocyte globulin and cyclosporine, hematopoietic stem cell transplantation, and growth factors. Prognosis depends on treatment, with 5-year survival rates of 68% with immunosuppression and 73% with stem cell transplantation.
Myelodysplastic syndrome (MDS)
This document describes myelodysplastic syndromes (MDS), a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis leading to peripheral blood cytopenias. It discusses the history of MDS classification including the French-American-British (FAB) and World Health Organization (WHO) systems. Key features of the different MDS subtypes are outlined along with associated cytogenetic abnormalities, predisposing factors, theories of pathophysiology, clinical manifestations, and diagnostic evaluation.
Aplastic anemia
This document summarizes the management of aplastic anemia. It discusses the classification, pathogenesis, clinical evaluation, investigations and definitive management including immunosuppressive therapy with antithymocyte globulin and cyclosporine. It also covers supportive management with transfusions, antibiotics and growth factors. Treatment failure options and hematopoietic stem cell transplantation are described. Inherited causes like Fanconi anemia are also summarized.
Refreactory anemia
Refractory anemia is a subtype of myelodysplastic syndrome characterized by non-responsiveness to conventional anemia treatment. It is defined by less than 5% blasts in the bone marrow and less than 1% in the peripheral blood. Refractory anemia involves dysplasia primarily affecting the erythroid lineage. Evaluation includes blood counts, peripheral smear, bone marrow biopsy and cytogenetic testing to confirm the diagnosis and guide prognosis. Management focuses on treating the anemia and related symptoms.
V_Hematology_Forum_Prof_Gujral
Myelodysplastic Syndrome (MDS) is a heterogeneous group of clonal hematopoietic stem cell disorders characterized by cytopenias, dysplastic changes in one or more myeloid cell lines, and a risk of progression to acute myeloid leukemia. MDS is not a single disease, but rather a spectrum of related disorders. Diagnosis involves evaluation of blood counts, peripheral smear, bone marrow aspirate/biopsy along with cytogenetics and molecular testing to identify abnormalities. Prognosis varies from indolent to high-risk of transformation based on the WHO classification which considers disease subtype, blast percentage, and cytogenetic risk factors.
Myelodysplastic syndrome by dr narmada
Myelodysplastic syndromes (MDS) are a group of bone marrow disorders characterized by ineffective blood cell production and shortages of normal blood cells. In MDS, the bone marrow cannot produce mature and fully functional blood cells. This leads to low blood cell counts and symptoms like anemia, fatigue, and infections. MDS has several subtypes classified by the FAB system based on blood cell dysplasia and percentage of blasts in the bone marrow, with some subtypes having a higher risk of progression to acute leukemia. Chromosomal abnormalities are common in MDS and help determine prognosis.
Fanconi anemia
Fanconi anemia is a rare genetic disorder that affects DNA repair and increases cancer risk. It is caused by mutations in one of several genes involved in the FA DNA repair pathway. Symptoms include bone marrow failure, physical abnormalities, and blood cancers. While there is no cure, treatment focuses on managing symptoms and complications through blood transfusions, antibiotics, bone marrow transplants, and cancer therapies.
Myelodysplastic Syndromes, Red Cell Transfusion
Myelodysplastic Syndromes, Red Cell Transfusion Presentation by Pr. David Bowen, St James’s Institute of Oncology, Leeds Teaching Hospitals, UK
Aplastic and hypoproliferative anemias
This document summarizes aplastic and hypoplastic anemias. Aplastic anemia is a life-threatening condition where the bone marrow fails to produce red blood cells, white blood cells, and platelets, leading to pancytopenia. It can be acquired through exposure to radiation, chemicals, infections or idiopathically. Congenital causes include Fanconi's anemia and familial aplastic anemia. Clinical manifestations include fatigue, pallor, infections, and bleeding. Treatment involves removing causative agents if known, blood transfusions, and bone marrow transplant. Related disorders with pancytopenia include myelodysplastic syndromes and pure red cell aplasia.
Mds
Myelodysplasia, also known as myelodysplastic syndrome (MDS), is a heterogeneous group of hematopoietic stem cell disorders that results in ineffective hematopoiesis and cytopenias. MDS is primarily seen in elderly patients and has a risk of progression to acute myeloid leukemia. Characteristic features include increased marrow proliferation, failure of stem cells to differentiate, and increased marrow apoptosis. Cytogenetic abnormalities are detected in 30-70% of patients and correlate with risk of progression. Treatment may include stem cell transplant, DNA methyltransferase inhibitors, immunotherapy, and chemotherapy.
Refractory anemia case report mds
A case report of MDS presenting as refractory anemia, followed by overview of treatment of MDS and comparison of hypomethylating agents (HMAs)
Aplastic anemia
This document defines and describes pancytopenia and various bone marrow conditions that can cause pancytopenia, including constitutional (inherited) and acquired aplastic anemia. Constitutional pancytopenias are inherited disorders resulting in low blood cell counts. Fanconi anemia is described as the most common constitutional disorder, caused by mutations on FANC genes involved in DNA repair. Acquired aplastic anemia has various etiologies including radiation, drugs, chemicals, viruses, immune diseases, and idiopathic causes. Bone marrow biopsy and chromosomal breakage studies are used in diagnosis. Treatment depends on severity but may include blood transfusions, hematopoietic stem cell transplant, growth factors, steroids, androg
Mds
Myelodisplastic syndrome
amirhossein heydarian
Iran- shahid beheshti medical university
www.amirhossein.heydarian@yahoo.com
Cardiovascular genetics
Cardiovascular genetics, Mendelian disorders, Marfans syndrome, Dilated Cardiomyopathy, Hypertrophic cardiomyopathy, Long Qt syndrome, Brugada syndrome, clopidogrel resistance
Aplastic anemia
This document discusses aplastic anemia, which is a condition characterized by pancytopenia (low red blood cells, white blood cells, and platelets) due to bone marrow failure. It can be acquired through exposure to drugs, radiation, chemicals, or viruses, or inherited through conditions like Fanconi anemia. Clinically, it presents with anemia, bruising, and increased infection risk. The bone marrow appears hypocellular on biopsy. Treatment involves managing symptoms, stopping any triggers, and attempts to restore bone marrow function through transplantation, immunosuppression, or growth factors.
Mds
Myelodysplastic syndrome (MDS) is a group of bone marrow disorders where the bone marrow fails to produce mature and healthy blood cells. This leads to low blood cell counts and a risk of developing acute myeloid leukemia. MDS is characterized by dysplasia in one or more cell lines and subgroups are defined by specific percentages of blasts in the bone marrow and blood. Common subgroups include refractory anemia, refractory anemia with ringed sideroblasts, and refractory anemia with excess blasts. Chromosomal abnormalities are present in many cases of MDS and help define prognosis.
Project proposal from venkatesh (bt)
This document presents a study plan to investigate molecular markers and toll-like receptor expression in myelodysplastic syndrome (MDS) patients in Assam, India. The study aims to measure mutation levels of genes like TET2, SAXL1, RUNX1, RAS, and TP53 in MDS patients and determine expression of toll-like receptors TLR1-10 at mRNA and protein levels. The methodology involves collecting blood samples from MDS patients, extracting RNA and protein, and using techniques like qRT-PCR, ELISA, western blotting, and flow cytometry for analysis. The expected significance is that the study may help explore gene expression and mutation patterns in MDS patients in Assam and support approaches for treating
Hypoplastic bone marrow syndromes
The document discusses bone marrow failure syndromes, which occur when there is a decrease or damage to hematopoietic stem cells and their microenvironment resulting in hypoplastic or aplastic bone marrow. Some examples of bone marrow failure syndromes discussed include aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, and various constitutional bone marrow failure syndromes such as Fanconi anemia, dyskeratosis congenita, and Diamond-Blackfan anemia. The causes, signs, diagnostic evaluation, and treatment approaches for different bone marrow failure syndromes are described.
Fanconi anemia, syndrome
This document discusses Fanconi syndrome and Fanconi anemia. Fanconi syndrome is a generalized proximal tubular defect in the kidneys causing defects in renal tubular reabsorption. It can be hereditary or acquired. Fanconi anemia is a rare inherited bone marrow failure syndrome associated with physical abnormalities and cancer predisposition. It is caused by mutations in genes involved in DNA repair. Supportive care includes transfusions and hematopoietic stem cell transplantation represents the only cure for hematological complications.
Pancytopenia Approach
Pancytopenia is a reduction in red blood cells, white blood cells, and platelets. The document outlines an approach to evaluating a case of pancytopenia, including considering decreased bone marrow production, increased cell destruction, a thorough history and physical exam, and diagnostic tests like complete blood count, peripheral smear, and bone marrow aspiration and biopsy to determine the underlying cause. The causes of pancytopenia are grouped based on mechanism and include conditions like aplastic anemia, megaloblastic anemia, myelodysplastic syndrome, liver disease, and others.
Recent advances in mds
The document discusses recent advances in myelodysplastic syndromes (MDS), including new risk stratification models, prognostic factors, and therapeutic options for lower-risk and higher-risk MDS such as lenalidomide for lower-risk MDS and azacitidine or allogeneic stem cell transplantation for higher-risk MDS. Clinical trials have shown that lenalidomide can induce transfusion independence in patients with MDS and del(5q) abnormality and azacitidine improves overall survival compared to
BiTE Presentation
Blinatumomab is a bispecific T cell engager (BiTE) antibody approved for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). It works by binding to CD19 on B-cells and CD3 on T-cells, bringing the cells together to trigger T-cell mediated killing of B-cells. Clinical trials showed 69% of patients achieved complete remission or partial recovery with 88% achieving minimal residual disease response. Common adverse events included cytokine release syndrome and nervous system toxicities which were often reversible. Blinatumomab treatment reduces relapse rates and improves overall survival for ALL patients by eliminating minimal residual disease.
Leukemia and lymphoma PATHOLOGY REVISION NOTES
PATHOLOGY REVISION NOTES BASED ON HIGH YIELD TOPICS
AND LECTURE NOTES
LEUKEMIA AND LYMPHOMA
HIGH YIELD TOPICS
MEDICINE HEMATOLOGY BASICS
IMAGE BASED QUESTIONS
PERIPHERAL SMEAR
Plab1 - Disease VS Treatment (Al-Hanif Foundation)
The document provides a summary of revision notes for the PLAB-1 exam, including information taken from sources like PLABKEYS, Google Images, and other medical student resources. The notes are intended as a quick review and not a replacement for textbooks. They were created by Dr. Shahbaz Hanif as a last minute study aid for the exam.
Plab1 - Mnemonics (Al-Hanif Foundation)
This document provides a brief summary of revision notes for the PLAB-1 exam intended for quick revision before the exam. The notes are drawn from various sources including PLABKEYS, Google Images, and other medical student study resources and tips. The document acknowledges its main sources as being PLABKEYS, an online resource called "Mnemonics and Study Tips for Medical Students," and Google Images.
More Related Content
What's hot
V_Hematology_Forum_Prof_Gujral
Myelodysplastic Syndrome (MDS) is a heterogeneous group of clonal hematopoietic stem cell disorders characterized by cytopenias, dysplastic changes in one or more myeloid cell lines, and a risk of progression to acute myeloid leukemia. MDS is not a single disease, but rather a spectrum of related disorders. Diagnosis involves evaluation of blood counts, peripheral smear, bone marrow aspirate/biopsy along with cytogenetics and molecular testing to identify abnormalities. Prognosis varies from indolent to high-risk of transformation based on the WHO classification which considers disease subtype, blast percentage, and cytogenetic risk factors.
Myelodysplastic syndrome by dr narmada
Myelodysplastic syndromes (MDS) are a group of bone marrow disorders characterized by ineffective blood cell production and shortages of normal blood cells. In MDS, the bone marrow cannot produce mature and fully functional blood cells. This leads to low blood cell counts and symptoms like anemia, fatigue, and infections. MDS has several subtypes classified by the FAB system based on blood cell dysplasia and percentage of blasts in the bone marrow, with some subtypes having a higher risk of progression to acute leukemia. Chromosomal abnormalities are common in MDS and help determine prognosis.
Fanconi anemia
Fanconi anemia is a rare genetic disorder that affects DNA repair and increases cancer risk. It is caused by mutations in one of several genes involved in the FA DNA repair pathway. Symptoms include bone marrow failure, physical abnormalities, and blood cancers. While there is no cure, treatment focuses on managing symptoms and complications through blood transfusions, antibiotics, bone marrow transplants, and cancer therapies.
Myelodysplastic Syndromes, Red Cell Transfusion
Myelodysplastic Syndromes, Red Cell Transfusion Presentation by Pr. David Bowen, St James’s Institute of Oncology, Leeds Teaching Hospitals, UK
Aplastic and hypoproliferative anemias
This document summarizes aplastic and hypoplastic anemias. Aplastic anemia is a life-threatening condition where the bone marrow fails to produce red blood cells, white blood cells, and platelets, leading to pancytopenia. It can be acquired through exposure to radiation, chemicals, infections or idiopathically. Congenital causes include Fanconi's anemia and familial aplastic anemia. Clinical manifestations include fatigue, pallor, infections, and bleeding. Treatment involves removing causative agents if known, blood transfusions, and bone marrow transplant. Related disorders with pancytopenia include myelodysplastic syndromes and pure red cell aplasia.
Mds
Myelodysplasia, also known as myelodysplastic syndrome (MDS), is a heterogeneous group of hematopoietic stem cell disorders that results in ineffective hematopoiesis and cytopenias. MDS is primarily seen in elderly patients and has a risk of progression to acute myeloid leukemia. Characteristic features include increased marrow proliferation, failure of stem cells to differentiate, and increased marrow apoptosis. Cytogenetic abnormalities are detected in 30-70% of patients and correlate with risk of progression. Treatment may include stem cell transplant, DNA methyltransferase inhibitors, immunotherapy, and chemotherapy.
Refractory anemia case report mds
A case report of MDS presenting as refractory anemia, followed by overview of treatment of MDS and comparison of hypomethylating agents (HMAs)
Aplastic anemia
This document defines and describes pancytopenia and various bone marrow conditions that can cause pancytopenia, including constitutional (inherited) and acquired aplastic anemia. Constitutional pancytopenias are inherited disorders resulting in low blood cell counts. Fanconi anemia is described as the most common constitutional disorder, caused by mutations on FANC genes involved in DNA repair. Acquired aplastic anemia has various etiologies including radiation, drugs, chemicals, viruses, immune diseases, and idiopathic causes. Bone marrow biopsy and chromosomal breakage studies are used in diagnosis. Treatment depends on severity but may include blood transfusions, hematopoietic stem cell transplant, growth factors, steroids, androg
Mds
Myelodisplastic syndrome
amirhossein heydarian
Iran- shahid beheshti medical university
www.amirhossein.heydarian@yahoo.com
Cardiovascular genetics
Cardiovascular genetics, Mendelian disorders, Marfans syndrome, Dilated Cardiomyopathy, Hypertrophic cardiomyopathy, Long Qt syndrome, Brugada syndrome, clopidogrel resistance
Aplastic anemia
This document discusses aplastic anemia, which is a condition characterized by pancytopenia (low red blood cells, white blood cells, and platelets) due to bone marrow failure. It can be acquired through exposure to drugs, radiation, chemicals, or viruses, or inherited through conditions like Fanconi anemia. Clinically, it presents with anemia, bruising, and increased infection risk. The bone marrow appears hypocellular on biopsy. Treatment involves managing symptoms, stopping any triggers, and attempts to restore bone marrow function through transplantation, immunosuppression, or growth factors.
Mds
Myelodysplastic syndrome (MDS) is a group of bone marrow disorders where the bone marrow fails to produce mature and healthy blood cells. This leads to low blood cell counts and a risk of developing acute myeloid leukemia. MDS is characterized by dysplasia in one or more cell lines and subgroups are defined by specific percentages of blasts in the bone marrow and blood. Common subgroups include refractory anemia, refractory anemia with ringed sideroblasts, and refractory anemia with excess blasts. Chromosomal abnormalities are present in many cases of MDS and help define prognosis.
Project proposal from venkatesh (bt)
This document presents a study plan to investigate molecular markers and toll-like receptor expression in myelodysplastic syndrome (MDS) patients in Assam, India. The study aims to measure mutation levels of genes like TET2, SAXL1, RUNX1, RAS, and TP53 in MDS patients and determine expression of toll-like receptors TLR1-10 at mRNA and protein levels. The methodology involves collecting blood samples from MDS patients, extracting RNA and protein, and using techniques like qRT-PCR, ELISA, western blotting, and flow cytometry for analysis. The expected significance is that the study may help explore gene expression and mutation patterns in MDS patients in Assam and support approaches for treating
Hypoplastic bone marrow syndromes
The document discusses bone marrow failure syndromes, which occur when there is a decrease or damage to hematopoietic stem cells and their microenvironment resulting in hypoplastic or aplastic bone marrow. Some examples of bone marrow failure syndromes discussed include aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, and various constitutional bone marrow failure syndromes such as Fanconi anemia, dyskeratosis congenita, and Diamond-Blackfan anemia. The causes, signs, diagnostic evaluation, and treatment approaches for different bone marrow failure syndromes are described.
Fanconi anemia, syndrome
This document discusses Fanconi syndrome and Fanconi anemia. Fanconi syndrome is a generalized proximal tubular defect in the kidneys causing defects in renal tubular reabsorption. It can be hereditary or acquired. Fanconi anemia is a rare inherited bone marrow failure syndrome associated with physical abnormalities and cancer predisposition. It is caused by mutations in genes involved in DNA repair. Supportive care includes transfusions and hematopoietic stem cell transplantation represents the only cure for hematological complications.
Pancytopenia Approach
Pancytopenia is a reduction in red blood cells, white blood cells, and platelets. The document outlines an approach to evaluating a case of pancytopenia, including considering decreased bone marrow production, increased cell destruction, a thorough history and physical exam, and diagnostic tests like complete blood count, peripheral smear, and bone marrow aspiration and biopsy to determine the underlying cause. The causes of pancytopenia are grouped based on mechanism and include conditions like aplastic anemia, megaloblastic anemia, myelodysplastic syndrome, liver disease, and others.
Recent advances in mds
The document discusses recent advances in myelodysplastic syndromes (MDS), including new risk stratification models, prognostic factors, and therapeutic options for lower-risk and higher-risk MDS such as lenalidomide for lower-risk MDS and azacitidine or allogeneic stem cell transplantation for higher-risk MDS. Clinical trials have shown that lenalidomide can induce transfusion independence in patients with MDS and del(5q) abnormality and azacitidine improves overall survival compared to
BiTE Presentation
Blinatumomab is a bispecific T cell engager (BiTE) antibody approved for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). It works by binding to CD19 on B-cells and CD3 on T-cells, bringing the cells together to trigger T-cell mediated killing of B-cells. Clinical trials showed 69% of patients achieved complete remission or partial recovery with 88% achieving minimal residual disease response. Common adverse events included cytokine release syndrome and nervous system toxicities which were often reversible. Blinatumomab treatment reduces relapse rates and improves overall survival for ALL patients by eliminating minimal residual disease.
Leukemia and lymphoma PATHOLOGY REVISION NOTES
PATHOLOGY REVISION NOTES BASED ON HIGH YIELD TOPICS
AND LECTURE NOTES
LEUKEMIA AND LYMPHOMA
HIGH YIELD TOPICS
MEDICINE HEMATOLOGY BASICS
IMAGE BASED QUESTIONS
PERIPHERAL SMEAR
What's hot (20)
More from Dr-SHAHBAZ HANIF
Plab1 - Disease VS Treatment (Al-Hanif Foundation)
The document provides a summary of revision notes for the PLAB-1 exam, including information taken from sources like PLABKEYS, Google Images, and other medical student resources. The notes are intended as a quick review and not a replacement for textbooks. They were created by Dr. Shahbaz Hanif as a last minute study aid for the exam.
Plab1 - Mnemonics (Al-Hanif Foundation)
This document provides a brief summary of revision notes for the PLAB-1 exam intended for quick revision before the exam. The notes are drawn from various sources including PLABKEYS, Google Images, and other medical student study resources and tips. The document acknowledges its main sources as being PLABKEYS, an online resource called "Mnemonics and Study Tips for Medical Students," and Google Images.
Plab1 - Odd Sign, Test or Terminology (Al-Hanif Foundation)
This document provides a quick summary of revision notes for the PLAB-1 exam in 3 sentences or less. It includes short notes taken from sources like PLABKEYS, Google Images, and other medical student resources to aid last minute exam preparation. The notes are acknowledged to not replace textbooks, but merely offer a high-level overview of key points for a concise exam revision.
Plab1 - Important Associations (Al-Hanif Foundation)
This document provides a quick revision summary for the PLAB-1 exam, with notes taken from sources like PLABKEYS, Google Images, and other medical student resources. It acknowledges key sources used like PLABKEYS, study tips websites, and Google Images. The notes are intended for last minute exam revision and not as a replacement for textbooks and references.
PLAB1 - Epidemiology (Al-Hanif Foundation)
Epidemiology is a summary of short revision notes for the PLAB-1 exam intended for quick revision points rather than replacing textbooks. The notes are compiled from sources like PLABKEYS, Google Images, and various medical student study resources. The document acknowledges the sources used to compile the summary revision notes.
1- Surgical Anatomy of the Retroperitoneal & Pelvic Extraperitoneal Space
This is the 1st chapter of Prof. Cheng-Hua Luo's book on Retroperitoneal Tumors (Clinical Management) 2018.
More from Dr-SHAHBAZ HANIF (6)
Plab1 - Disease VS Treatment (Al-Hanif Foundation)
Plab1 - Disease VS Treatment (Al-Hanif Foundation)
Plab1 - Odd Sign, Test or Terminology (Al-Hanif Foundation)
Plab1 - Odd Sign, Test or Terminology (Al-Hanif Foundation)
Plab1 - Important Associations (Al-Hanif Foundation)
Plab1 - Important Associations (Al-Hanif Foundation)
1- Surgical Anatomy of the Retroperitoneal & Pelvic Extraperitoneal Space
1- Surgical Anatomy of the Retroperitoneal & Pelvic Extraperitoneal Space
Recently uploaded
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
cosmetics and cosmeceuticals
Muskan
mpharm
2nd semester
Guru Gobind Singh college of pharmacy, yamunanagar, haryana
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
What is Obesity? How to overcome Obesity?
Obesity is a chronic complex disease defined by excessive fat deposits that can impair health.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort. Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Nano-gold for Cancer Therapy chemistry investigatory project
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Recently uploaded (20)
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Plab1 - Genetic and Chromosomal Disorders (Al-Hanif Foundation)
- 1. Autosomal Recessive Autosomal Dominant X-linked Recessive Trisomies • Cong. Ad. Hyperplasia • Cystic Fibrosis • Gilbert Synd • Hemochromatosis • Sickle Cell Anemia • Thalassemia • Wilson Disease 25% • ADPKD • BRCA (1, 2) • Familial Hypercholesterolemia • Huntington • Hereditary Spherocytosis • Hereditary Angioedema • Neurofibromatosis • Marfan Synd • Osteogenesis Imperfecta • Von Willebrand Disease 50% • Becker MD • Duchene MD • G6PD • Hemophilia • Turner Synd Male 50% • Patao (13) • Edward (18) • Down (21) Affected (have the disease)